Lundbeck Has Relocated US Headquarters to Greater Boston
The pharmaceutical company is shifting its US operations to Massachusetts to leverage local talent and research institutions.
Updated on Sept. 25, 2026 in Alzheimer’s
Live Poll
Do you believe moving corporate headquarters to major industry hubs improves long-term business performance?
Lundbeck has announced it will move its US headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts. The company is also establishing a new global innovation hub to support its long-term growth and neuroscience portfolio.
Why it matters
The move aligns with the company's Focused Innovator strategy by positioning the firm closer to major academic and healthcare institutions. This proximity is intended to improve access to scientific talent and foster new innovation opportunities.
Lundbeck currently employs over 5,000 people globally and operates in 20 countries. Its products are available in 80 countries, backed by 70 years of experience in the neuroscience field.
The players
Lundbeck
This global pharmaceutical company specializes in brain diseases and maintains its worldwide headquarters in Copenhagen, Denmark.
The details
The transition from the current Deerfield base will occur over the next year while the firm retains its existing US team. The company already maintains a presence in Cambridge, Massachusetts, which will serve as a foundation for this expansion.
Timeline
September 25, 2026: The headquarters relocation was officially announced.
Next year: The planned transition period for moving US operations.
The Big Picture
Lundbeck's move reflects the ongoing trend of major biopharmaceutical companies consolidating their research and administrative operations within the Greater Boston life sciences cluster. This geographic shift highlights the region's status as a central hub for global neuroscience innovation.
The expansion of the company's innovation hub may accelerate the development of new treatments for neurological conditions. Residents in the area may also see increased job opportunities within the biotech and clinical research sectors over the coming year.
The takeaway
This transition highlights how established pharmaceutical firms are increasingly prioritizing physical proximity to academic research hubs to drive drug development. It serves as a indicator of the competitive importance of regional innovation ecosystems in the modern biotech industry.
Further reading
Learn more about local industry developments and research in the Massachusetts Alzheimer’s section.
More information
For additional corporate details, visit the Lundbeck corporate website.
Live Poll
Do you believe moving corporate headquarters to major industry hubs improves long-term business performance?
